Cancer stem cells in oncology

Journal of B.U.ON.

Volumn 17, Issue 4, 2012, Pages 644-648

  Cetin, Idil ^a   Topcul, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cancer; Cancer stem cells; CSC targeted therapies; Diagnosis; Prognosis; Therapeutic resistance

Indexed keywords

CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CARCINOGENICITY; CELL KILLING; CELL RENEWAL; HUMAN; METASTASIS; ONCOLOGY; PLURIPOTENT STEM CELL; REVIEW;

ANIMALS; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; PROGNOSIS;

EID: 84872367095     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Ruddon RW. Characteristics of human cancer. In: Ruddon RW(Ed): Cancer Biology (4th Edn). Oxford University Press, New York, 2007, pp 3-61.
2. Elsa Q, Mark S, Hannah RF et al. Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized. Cancer Cell 2010; 18: 510-523.
3. Franziska M, Komelia P. The origins and implications of intratumor heterogeneity. Cancer Prev Res 2010; 3: 1361-1364.
4. Yoh I, Franziska M. Evolutionary dynamics of intratumor heterogeneity. PLoS ONE, www.plosone.org. 2011; 6: 1-8.
5. Wei G, Joseph LL, Hong W. Cancer stem cells. Pediatric Res 2006; 59: 59-64.
6. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Stem Cells 2008; 1: 267-284.
7. O'Brien CA, Kreso A, Jamieson CHM. Cancer stem cells and self-renewal. Clin Cancer Res 2010; 16: 3113-3120.
8. Hurt EM, Farrar WL. Purification and characterization of cancer stem cells. In: Farrar WL (Ed): Cancer Stem Cells. Cambridge University Press, Cambridge, 2010, pp 1-14.
9. Pardal R, Clarke MF Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3: 895-902. (Pubitemid 37500174)
10. Borovski T, De Sousa E Melo F, Vermeulen L et al. Cancer stem cell niche: the place to be. Cancer Res 2011; 71: 634-639.
11. Buchstaller J, Quintana E, Morrison SJ. Cancer stem cells. In: Mendelsohn AC, Howley A, Israel S, Gray JE, Lindsten T (Eds): The molecular basis of cancer (3rd Edn). Elsevier, Philadelphia, 2008, pp 141-154.
12. Klonisch T, Wiechec E, Hombach-Klonisch S, et al. Cancer stem cell markers in common cancers - therapeutic implications, Trends Mol Med 2008; 14: 450-460.
13. Honoki K, Fujii H, Tsujiuchi T. Cancer stem cell niche: the role of mesenchymal stem cells in tumor microenvironment. In: Shostak S(Ed): Cancer Stem Cells-The Cutting Edge. InTech, Croatia, 2011, pp 189-206.
14. Bapat S, Collins A, Dean M, Nephew K, Rasheed S. Cancer stem cells: similarities and variations in the theme of normal stem cells. In: Bapat S (Ed): Cancer Stem Cells Identification and Targets. John Wiley & Sons, New Jersey, Canada, 2009, pp 1-26.
15. Li L, Xie T. Stem cell niche: structure and function. Annu Rev Cell Develop Biol 2005; 21: 605-631. (Pubitemid 41740648)
16. Cheng L, Zhang S, Davidson DD, Montironi R, Lopez-Beltran A. Implications of cancer stem cells for cancer therapy. In: Bagley RG, Teicher BA (Eds): Stem Cells and Cancer. Humana Press, New York, 2009, pp 255-262.
17. Morrison R, Schleicher SM, Sun Y et al. Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol 2011; 2011: 941876. Epub 2010 Oct 12.
18. Clayton S, Mousa SA. Therapeutics formulated to target cancer stem cells: Is it in our future? Cancer Cell International 2011; 11: 1-9.
19. Choi D, Lee HW, Hur KY et al. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol 2009; 15: 2258-2264.
20. Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-1037.
21. Efstathiou E, Logothetis CJ. Clinical challenges for treatment and cure. In: Pardee AB, Stein GS (Eds): The Biology and Treatment of Cancer; Understanding Cancer. John Wiley & Sons, New Jersey, Canada, 2009, pp 155-167.
22. Sabisz M, Skladanowski A. Cancer Stem Cells in Drug Resistance and Drug Screening: Can We Exploit the Cancer Stem Cell Paradigm in Search for New Antitumor Agents? In: Shostak S (Ed): Cancer Stem Cells Theories and Practice. InTech, India, 2011, pp 423-42.
23. Schatten T, Frank NY, Frank MH. Solid tumor stem cells - implications for cancer therapy. In: Rajasekhar VK, Phil M, Vemuri MC (Eds): Regulatory Networks in Stem Cells. Humana Press, New York, 2009, pp 527-543.
24. Rich JN. Cancer stem cells in radiation resistance. Cancer Res 2007; 67: 8980-8984. (Pubitemid 47535877)
25. Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 2006; 98: 1755-1757. (Pubitemid 46017927)
26. Sell S, Glinsky G. Preventative and therapeutic strategies for cancer stem cells. In: Farrar WL (Eds): Cancer Stem Cells. Cambridge University Press, Cambridge, 2010, pp 68-92.
27. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 2006; 66: 1883-1890.
28. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005; 5: 275-284. (Pubitemid 40488633)
29. Donnenberg VS, Meyer EM, Donnenberg AD. Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells. In: Yu JS (Ed): Cancer Stem Cells Methods and Protocols. Humana Press, New York, 2009, pp 261-279.
30. Naoki O, Xin WW. Novel Therapeutic Strategies for Targeting Liver Cancer Stem Cells. Int J Biol Sci 2011; 7: 517-535.
31. Christopher YP, Diane T, Irving LW. Cancer Stem Cell-Direct-ed Therapies: Recent Data From the Laboratory and Clinic. Mol Therapy 2009; 17: 219-230.
32. Sagrera A, Pérez-Losada J, Pérez-Caro M, Jiménez R, Sánchez-García I, Cobaleda C. Elimination of cancer stem cells. In: DittmarT, Zänker KS (Eds): Stem Cell Biology in Health and Disease. Springer, London, New York, 2009, pp 364-377.